1031927-08-8 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 4-(2-oxo-1,3-oxazinan-3-yl)benzoate is used as a smooth muscle relaxant and vasodilator for the treatment of various gastrointestinal and circulatory disorders. Its application is based on its ability to inhibit the intracellular accumulation of calcium ions, leading to the relaxation of smooth muscle and improved blood flow.
Used in Gastrointestinal Disorders Treatment:
Methyl 4-(2-oxo-1,3-oxazinan-3-yl)benzoate is used as a therapeutic agent for conditions such as irritable bowel syndrome and abdominal pain, where its muscle relaxant properties help alleviate symptoms and improve patient comfort.
Used in Circulatory Disorders Treatment:
In the treatment of peripheral vascular disease, Methyl 4-(2-oxo-1,3-oxazinan-3-yl)benzoate is used to enhance blood flow and improve circulation, providing relief from symptoms associated with poor blood supply to the extremities.
Used in Drug Development:
Methyl 4-(2-oxo-1,3-oxazinan-3-yl)benzoate also presents potential applications in the development of novel drugs for gastrointestinal and circulatory disorders, offering a foundation for research into new treatment options and pharmaceutical formulations.
Check Digit Verification of cas no
The CAS Registry Mumber 1031927-08-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,1,9,2 and 7 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1031927-08:
(9*1)+(8*0)+(7*3)+(6*1)+(5*9)+(4*2)+(3*7)+(2*0)+(1*8)=118
118 % 10 = 8
So 1031927-08-8 is a valid CAS Registry Number.
1031927-08-8Relevant articles and documents
SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor Xa
Qiao, Jennifer X.,Chang, Chong-Hwan,Cheney, Daniel L.,Morin, Paul E.,Wang, Gren Z.,King, Sarah R.,Wang, Tammy C.,Rendina, Alan R.,Luettgen, Joseph M.,Knabb, Robert M.,Wexler, Ruth R.,Lam, Patrick Y.S.
, p. 4419 - 4427 (2008/02/10)
In the search of Factor Xa (FXa) inhibitors structurally different from the pyrazole-based series, we identified a viable series of enantiopure cis-(1R,2S)-cycloalkyldiamine derivatives as potent and selective inhibitors of FXa. Among them, cyclohexyldiam